Multi-Ethnic Study of Atherosclerosis (MESA): Overview and Protocol

This entry is not a study but the description of one — and that one, the Multi-Ethnic Study of Atherosclerosis, is among the most consequential cardiovascular cohorts ever assembled. We include it because so much of what this library cites traces back to it.

Begun in 2000, MESA enrolled 6,814 adults aged 45–84 with no cardiovascular disease at baseline, deliberately diverse by ancestry, then followed them for more than two decades. Its defining choice was to study subclinical disease — atherosclerosis forming silently before any event — which is exactly the window BlueRipple cares about. The payoff includes much of the validation behind coronary calcium scoring, the MESA risk calculator, and a great deal of what’s known about why cardiovascular risk varies across populations.

The practical takeaway is interpretive: when a study cites “MESA data,” it is leaning on a large, rigorous, publicly available cohort with central reading and excellent retention — a strong foundation.

We rate the evidence very high — not for this webpage, but for the cohort it describes: a gold-standard NHLBI prospective study with 20-plus years of follow-up that has shaped prevention guidelines. Its clinical significance here is moderate, because this is reference material about a study’s design rather than a finding in its own right — context for reading everything MESA has produced.